SEVERANCE AGREEMENTSeverance Agreement • September 26th, 2017 • Cti Biopharma Corp • Pharmaceutical preparations • Washington
Contract Type FiledSeptember 26th, 2017 Company Industry JurisdictionTHIS SEVERANCE AGREEMENT (this “Agreement”) is made and entered into this 25th day of September, 2017 (the “Effective Date”), by and between CTI BioPharma Corp., a Washington corporation (the “Company”), and David Kirske (the “Executive”).
SEVERANCE AGREEMENTSeverance Agreement • February 17th, 2016 • Cti Biopharma Corp • Pharmaceutical preparations • Washington
Contract Type FiledFebruary 17th, 2016 Company Industry JurisdictionTHIS SEVERANCE AGREEMENT (this “Agreement”) is made and entered into effective on the 27th day of July 2015 (the “Effective Date”), by and between CTI BioPharma Corp., a Washington corporation (the “Company”), and Bruce J. Seeley (the “Executive”).
SEVERANCE AGREEMENTSeverance Agreement • March 12th, 2015 • Cti Biopharma Corp • Pharmaceutical preparations • Washington
Contract Type FiledMarch 12th, 2015 Company Industry JurisdictionTHIS SEVERANCE AGREEMENT (this “Agreement”) is made and entered into this _____ day of _________ 20___ (the “Effective Date”), by and between CTI BioPharma Corp., a Washington corporation (the “Company”), and [______________] (the “Executive”).